In complicated UTI or pyelonephritis, cefepime-enmetazobactam increased success vs. piperacillin-tazobactam at 14 d

被引：1
|
作者：
Maki, Dennis G. [1 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 02期
关键词：
D O I：
10.7326/J22-0114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：JC21 / JC21
页数：1
相关论文
共 6 条
  • [1] Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis
    Hsu, Chi-Kuei
    Tsai, Wen-Wen
    Lai, Chih-Cheng
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (08): : 684 - 685
  • [2] Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis Reply
    Kaye, Keith S.
    Belley, Adam
    Velicitat, Patrick
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (08): : 685 - 685
  • [3] Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis A Randomized Clinical Trial
    Kaye, Keith S.
    Belley, Adam
    Barth, Philip
    Lahlou, Omar
    Knechtle, Philipp
    Motta, Paola
    Velicitat, Patrick
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (13): : 1304 - 1314
  • [4] Pharmacoeconomics of Ciprofloxacin plus Metronidazole vs. Piperacillin-Tazobactam for Complicated Intra-Abdominal Infections
    Paladino, Joseph A.
    Gilliland-Johnson, Kristin K.
    Adelman, Martin H.
    Cohn, Stephen M.
    SURGICAL INFECTIONS, 2008, 9 (03) : 325 - 333
  • [5] Re-assessment of the primary efficacy outcomes of cefepime/enmetazobactam versus piperacillin/tazobactam in adult patients with complicated urinary tract infections or acute pyelonephritis using updated EUCAST piperacillin/tazobactam susceptibility breakpoints
    Ward, Jon
    Belley, Adam
    Quevedo, Juan
    Dunkel, Nathalie
    Velicitat, Patrick
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6
  • [6] In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d
    Granwehr, Bruno
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (06) : JC67
1